Medical News

RSS

American-style diet plays a vital role in prostate cancer, researchers say

Elevated fat and cholesterol levels found in a typical American-style diet plays an important role in the growth and spread of prostate cancer, say researchers at Thomas Jefferson University's Kimmel Cancer Center.

2 Dec 2010

Endo acquires Qualitest Pharmaceuticals

Endo Pharmaceuticals (Nasdaq: ENDP) announced today the completion of its acquisition of Qualitest Pharmaceuticals. Endo announced Sept. 28 that it entered into a definitive agreement to acquire Qualitest Pharmaceuticals, a leading, privately held generics company in the U.S., for approximately $1.2 billion in cash.

2 Dec 2010

Report analyzes global health funding trends, predicts lower funding growth

A report from the Institute for Health Metrics and Evaluation (IHME) finds that the recent global economic downturn "hasn't quelled generous government and private donors from giving record amounts to improve global health," but the analysis also revealed "that growth in funding is beginning to taper off, cut by more than half between 2008 and 2010," the Seattle Times' "The Business of Giving" blog reports (Heim, 11/30).

2 Dec 2010

International trial confirms long-term benefits of anastrozole to stop breast cancer

A major international trial has confirmed the long-term benefit of anastrozole to help stop breast cancer coming back or developing in the other breast in postmenopausal women with hormone sensitive early breast cancer, according to a study published in Lancet Oncology today (Wednesday).

2 Dec 2010

GSK and Valeant receive FDA Complete Response letter for ezogabine

GlaxoSmithKline and Valeant Pharmaceuticals International, Inc. announced receipt of a Complete Response letter from the U.S. Food and Drug Administration (FDA) for the New Drug Application (NDA) for ezogabine, an investigational anti-epileptic drug being studied for the adjunctive treatment of adults with partial-onset seizures.

2 Dec 2010

Genzyme sells genetics business to LabCorp for $925M

Genzyme Corporation today announced that it has completed the sale of Genzyme Genetics to Laboratory Corporation of America Holdings (NYSE: LH) for $925 million in cash.

2 Dec 2010

Republicans fight over energy and commerce gavel as they sharpen congressional agenda

Republicans are fighting over the gavel to head the Energy and Commerce committee as their agenda's outline becomes sharper in anticipation of the new session of Congress.

2 Dec 2010

GE Healthcare launches eHealth Image Exchange software solution

GE Healthcare today announced its eHealth Image Exchange software solution: a flexible, standards-based platform for sharing images and integrating workflows across a healthcare community.

2 Dec 2010

Collegium completes spin-out of Onset Therapeutics

Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, announced today that it has completed the spin-out of Onset Therapeutics, LLC, its wholly owned subsidiary focused on the Dermatology market.

2 Dec 2010

States struggle with significant financial budget strains, especially in Medicaid; Others position for innovative coverage efforts

Bloomberg: "U.S. states expect 'significant challenges' balancing budgets in the next two years, after closing $230 billion in gaps since 2009, as U.S. stimulus aid drops and tax receipts recover from the recession, a study said. While state spending is set to rise for the current fiscal year compared with 2010, after two straight annual declines, governments will face renewed pressure in 2012, according to the study released today by the National Governors Association. The budget period begins in July in 46 states.

2 Dec 2010

Daiichi Sankyo completes patient enrollment in Phase III edoxaban study for AF

Daiichi Sankyo Company, Limited (TSE: 4568) announced today that it has successfully completed patient enrollment for its Phase III ENGAGE AF-TIMI 48 clinical study of edoxaban, a direct, specific, oral Factor Xa inhibitor that is being investigated in two different dosing regimens given once daily, to prevent the occurrence of strokes and systemic embolic events (SEE) in patients with atrial fibrillation (AF).

2 Dec 2010

FDA approves CUBICIN 2-minute IV injection for MRSA skin infections, bacteremia

Cubist Pharmaceuticals, Inc. today announced that its currently-marketed antibiotic, CUBICIN (daptomycin for injection), has been approved by the U.S. Food & Drug Administration (FDA) for once-a-day dosing as a 2-minute intravenous (IV) injection.

2 Dec 2010

Mindray launches V Series patient monitoring system

Mindray Medical International Limited, a leading developer, manufacturer and marketer of medical devices worldwide, today introduced the Mindray V Series patient monitoring system, an all new scalable platform that focuses on the clarity and continuity of data at a single point of care. The V Series solution is the result of research focused on identifying the unique challenges of critical care and other high acuity environments.

From Mindray 2 Dec 2010

Medical groups weigh in on health reform, pay freeze

News outlets report on how new treatment models impact care, as well as political developments and positions among medical organizations.

2 Dec 2010

Oncolytics initiates enrollment in Phase II ovarian cancer study

Oncolytics Biotech Inc. announced today the start of enrollment in a randomized Phase II ovarian cancer study. The Gynecologic Oncology Group (GOG) is conducting the randomized Phase II trial of weekly paclitaxel versus weekly paclitaxel with REOLYSIN in patients with persistent or recurrent ovarian, fallopian tube or primary peritoneal cancer (GOG186H).

2 Dec 2010

Oramed announces publication of GLP-1 analog formulation in Journal of Diabetes

Oramed Pharmaceuticals Inc. a developer of oral drug delivery solutions, announces a publication in the Journal of Diabetes Science and Technology's November issue describing evaluation of the company's glucagon-like peptide- (GLP-1) analog formulation (ORMD-0901) in regulating glucose excursions in animal models.

2 Dec 2010

Worm eggs may heal ulcerative colitis: Research

A new study involving a man who swallowed worm eggs to relieve symptoms of ulcerative colitis sheds light on how worms promote healing in the intestine. The study, published today in Science Translational Medicine, also identifies potential targets for more conventional ways of treating colitis, an inflammatory bowel disease.

2 Dec 2010